CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
OPERATING ACTIVITIES
Net income including non-controlling interests	$ 19,018	$ 19,758
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:
Depreciation and amortization	7,269	6,210
Provision for doubtful accounts	2,716	2,962
Loss on sale of fixed assets	83	31
Equity-based awards compensation expense	3,410	3,748
Deferred income tax	291	3,238
Changes in operating assets and liabilities:
Increase in patient accounts receivable	(1,914)	(2,548)
(Increase) decrease in accounts receivable - other	(4,736)	116
Increase in other assets	(787)	(4,979)
Increase in accounts payable and accrued expenses	8,126	3,582
Increase in mandatorily redeemable non-controlling interests	7,069	5,372
Increase in other liabilities	286	1,506
Net cash provided by operating activities	40,831	38,996
INVESTING ACTIVITIES
Purchase of fixed assets	(5,576)	(5,620)
Purchase of businesses, net of cash acquired	(33,740)	(12,958)
Acquisitions of non-controlling interests	0	(664)
Proceeds on sale of fixed assets, net	67	42
Net cash used in investing activities	(39,249)	(19,200)
FINANCING ACTIVITIES
Distributions to non-controlling interests	(3,698)	(4,441)
Cash dividends paid to shareholders	(7,547)	(6,382)
Proceeds from revolving line of credit	63,000	128,000
Payments on revolving line of credit	(53,000)	(136,000)
Payments to settle mandatorily redeemable non-controlling interests	(2,230)	(1,136)
Principal payments on notes payable	(776)	(592)
Other	40	1
Net cash used in financing activities	(4,211)	(20,550)
Net increase in cash and cash equivalents	(2,629)	(754)
Cash and cash equivalents - beginning of period	20,047	15,778
Cash and cash equivalents - end of period	17,418	15,024
Cash paid during the period for:
Income taxes	8,059	10,051
Interest	1,616	770
Non-cash investing and financing transactions during the period:
Purchase of business - seller financing portion	1,650	500
Acquisition of non-controlling interest - seller financing portion	0	388
Payment to settle redeemable non-controlling interest - financing portion	0	126
Sale of non-controlling interests	$ 0	$ (148)